Parathyroid hormone measurement in chronic kidney disease an evolving issue for the nephrologist and the clinical laboratorist: Minireview

Mario Correale

Research output: Contribution to journalArticlepeer-review

Abstract

Parathyroid hormone (PTH) is the polypeptide hormone produced by the parathyroid glands, which plays a central role in calcium homeostasis. Circulating PTH must be measured regularly in patients with chronic kidney disease (CKD) mineral and bone disorders (MBD) to monitor and to adapt treatment with the aim of maintaining PTH levels within a defined narrow range of optimal values for each stage of CKD. Often, for the nephrologists, it is not easy to determine what PTH levels are clinically appropriate. Moreover, the PTH determination also shows many criticisms from the laboratory point of view and there is a clear need to standardize PTH measurements in every phase of the process: pre-analytical, analytical and post-analytical. In this review, all these aspects are summarized with particular reference to the most recent opportunities to improve PTH assays quality on the whole. To this aim, a closer cooperation between nephrologists and clinical laboratories is undoubtedly necessary.

Original languageEnglish
Pages (from-to)541-547
Number of pages7
JournalImmunopharmacology and Immunotoxicology
Volume34
Issue number4
DOIs
Publication statusPublished - Aug 2012

Keywords

  • Chronic kidney disease
  • Immunoassays
  • Mineral and bone disorders
  • Parathyroid hormone
  • PTH fragments

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology
  • Toxicology

Fingerprint Dive into the research topics of 'Parathyroid hormone measurement in chronic kidney disease an evolving issue for the nephrologist and the clinical laboratorist: Minireview'. Together they form a unique fingerprint.

Cite this